A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Applying to The University of Chicago · Chicago, Illinois
Answer a few short questions to share with the research team.